Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
This study has been terminated.
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00000600
  Purpose

This study will evaluate the effects of vitamin E supplementation in retarding the progression of common carotid artery intima-media thickening in African Americans.


Condition Intervention Phase
Cardiovascular Diseases
Carotid Artery Diseases
Intracranial Arteriosclerosis
Cerebrovascular Disorders
Heart Diseases
Vascular Diseases
Atherosclerosis
Drug: Vitamin E
Drug: Vitamin C
Phase II

MedlinePlus related topics: Antioxidants Carotid Artery Disease Heart Diseases Vascular Diseases
Drug Information available for: Vitamin E alpha-Tocopherol alpha-Tocopheryl acetate Tocopherols Ascorbic acid
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Placebo Control
Official Title: Antioxidants and Prevention of Early Atherosclerosis

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Primary Outcome Measures:
  • rate of change in average common carotid artery intima-media thickness (measured over 24 months)

Study Start Date: June 1995
Detailed Description:

BACKGROUND:

Evidence from epidemiologic studies, and from one unpublished study, suggests that greater intake of antioxidant vitamins is associated with reduced risk of coronary heart disease and stroke. Findings from an animal model indicate that increased intake of antioxidant vitamins prevents progression of aortic fatty streaks induced by an atherogenic diet, but not from more advanced injury-induced lesions. These observations suggest the hypothesis that increased antioxidant vitamin intake may prevent further progression of early atherosclerosis, possibly by means of reduced susceptibility of low density lipoprotein to oxidative modification and consequent cytotoxic, chemotactic, chemostatic, and unregulated uptake effects.

A new, automated, low-cost, portable ultrasound system for determining intima-media thickness of the common carotid artery makes it feasible to test the primary prevention impact of antioxidant vitamins on early atherosclerosis. Results of two studies at the University of Southern California suggest that the low-density lipoprotein effects on common carotid artery intima-media thickness can be detected by automated methods within 12 to 24 months in small patient samples. Retardation of intima-media thickness progression was achieved in both studies without significant changes in average vessel diameter, which suggests effects on early atherosclerotic lesions.

DESIGN NARRATIVE:

Patients will be screened for carotid intima-media thickness at home or at schools in mobile vans equipped with portable ultrasound equipment. After 12 months, those patients above the age and sex-adjusted 66th percentile at Screen I will be re-screened (Screen II), and those showing the greatest progression in intima-media thickness will be invited to participate in a trial run-in to assess vitamin E compliance. Patients will be randomized to the following four groups: 1) vitamin E (573 mg/day); 2) vitamin C; 3) Vitamin E and C combined; and 4) placebo. Common carotid artery intima-media thickness will be observed by ultrasound at 12- and 24-month follow-ups. The primary outcome is 24-month rate of change in average common carotid artery intima-media thickness.

  Eligibility

Ages Eligible for Study:   35 Years to 59 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • African American
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000600

Sponsors and Collaborators
Investigators
Principal Investigator: James H. Dwyer, III University of Southern California
  More Information

Study ID Numbers: 106, U01 HL52073
Study First Received: October 27, 1999
Last Updated: October 25, 2006
ClinicalTrials.gov Identifier: NCT00000600  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Atherosclerosis
Arterial Occlusive Diseases
Tocopherol acetate
Heart Diseases
Vascular Diseases
Disease Progression
Central Nervous System Diseases
Constriction, Pathologic
Arteriosclerosis
Brain Diseases
Cerebrovascular Disorders
Intracranial Arterial Diseases
Alpha-Tocopherol
Tocopherols
Intracranial Arteriosclerosis
Carotid Stenosis
Vitamin E
Carotid Artery Diseases
Ascorbic Acid

Additional relevant MeSH terms:
Antioxidants
Molecular Mechanisms of Pharmacological Action
Growth Substances
Vitamins
Physiological Effects of Drugs
Nervous System Diseases
Cardiovascular Diseases
Micronutrients
Protective Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 13, 2009